These findings suggested that SPP2 and ADH4 might have played distinct roles in the progression and metastasis of malignant cells in relapsed liver cancer, thereby holding promise as therapeutic targets for relapsed HCC. The gene discussed is ADH4; the disease is hepatocellular carcinoma.